Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Back to Journals Journal of Inflammation Research Volume 17 Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors Authors Rahim K, Shan M, Ul Haq I, Nawaz MN , Maryam S , Alturki MS, Al Khzem AH , Metwally K, Cavalu S, Alqifari SF , Yahya G Received 18 October 2023 Accepted for publication 9 March 2024 Published 23 March 2024 Volume 2024:17 Pages 18971917 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Adam Bachstetter Kashif Rahim, 1 Muhammad Shan, 2 Ihtisham Ul Haq, 3 5 Muhammad Naveed Nawaz, 2 Sajida Maryam, 3, 4 Mansour S Alturki, 6 Abdulaziz H Al Khzem, 6 Kamel Metwally, 7 Simona Cavalu, 8 Saleh F Alqifari, 9 Galal Yahya 10 1 School of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, Peoples Republic of China
We'll notify you when consultations and ordering open
MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response
Park Ji-youn, founder of Ozhean Skin and Plastic Surgery Network
Mama didn't raise no fool
It was known by other names including sulfation factors, non-suppressible insulin-like activity, multiplication stimulating activity and somatomedins
US$ 20.66
US$ 22.02
US$ 25.56
US$ 24.92
US$ 24.21
US$ 21.86
/sc-assets/prd/practices/cdcd65da-a892-465a-aa2c-48d5c1f8134f/Semaglutide%20vial.png)
